SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...

Arthur Klausner to sit on the "VC Check-Up" panel at the "Life Sciences & Healthcare Venture Summit 2008" in New York City
News | 10. 30. 2008